Walsh D A, Mapp P I, Wharton J, Rutherford R A, Kidd B L, Revell P A, Blake D R, Polak J M
Inflammation Group, London Hospital, Whitechapel, United Kingdom.
Ann Rheum Dis. 1992 Mar;51(3):313-7. doi: 10.1136/ard.51.3.313.
The neuropeptide substance P is found in perivascular and free unmyelinated nerve fibres in human synovial tissue. Quantitative receptor autoradiography was used to show specific, high affinity (Kd = 0.75 (0.21), nmol/l (mean (standard error of the mean)), low capacity (Bmax = 27.8 (7.9) amol/mm2) binding sites for substance P Bolton Hunter-labelled with iodine-125 localised to vascular endothelial cells in human synovial tissue. The binding could be saturated, was reversible, and was dependent on the magnesium concentration. Unlabelled substance P and neurokinin A competitively inhibited specific binding with 50% inhibition at concentrations of 1.25 (0.21) and 175 (29) nmol/l respectively. Neurokinin B (mumol/l) and calcitonin gene related peptide (1 mumol/l) did not inhibit binding. These binding sites show characteristics of the neurokinin 1 tachykinin receptor subtype. This provides further evidence that substance P may play a part in the vascular control of human synovium and may influence inflammatory processes in joints.
神经肽P物质存在于人类滑膜组织的血管周围和游离无髓神经纤维中。采用定量受体放射自显影法显示,用125碘标记的博尔顿·亨特P物质在人类滑膜组织的血管内皮细胞中有特异性、高亲和力(解离常数Kd = 0.75(0.21)nmol/l(均值(均值标准误)))、低容量(最大结合量Bmax = 27.8(7.9)amol/mm2)的结合位点。该结合可饱和、可逆,且依赖于镁离子浓度。未标记的P物质和神经激肽A竞争性抑制特异性结合,分别在浓度为1.25(0.21)和175(29)nmol/l时抑制率达50%。神经激肽B(μmol/l)和降钙素基因相关肽(1μmol/l)不抑制结合。这些结合位点显示出神经激肽1速激肽受体亚型的特征。这进一步证明P物质可能在人类滑膜的血管控制中起作用,并可能影响关节的炎症过程。